Cholangiocarcinoma Foundation Australia Partners with Genomic Focus By Steve|2024-03-01T17:02:33+13:00February 29th, 2024|Media| Read More 0
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2023-08-30T16:28:25+12:00August 29th, 2023|All, Media, Updates| Read More 0
Vyriad Expands Phase 1 Trial to Test Voyager-V1 By Steve|2018-07-28T06:11:12+12:00July 28th, 2018|All, IMMUNOTHERAPY, Media, TRIALS| Read More 0